LEPU BIO (02157) received an increase in holdings of 1.05 million H shares by Chairman and Executive Director Pu Zhongjie.
LEPU BIO (02157) announced that the Board was notified by Dr. Pu Zhongjie (Dr. Pu, Chairman and Executive Director, and a controlling shareholder of the Company) that on October 27, 2026, he purchased a total of 1.05 million H shares of the Company (H Shares) in the open market through the Shanghai-Hong Kong Stock Connect using his own funds at an average price of approximately RMB3.04 per H Share (approximately HK$3.55), representing approximately 0.06% of the total number of issued shares of the Company as at the date of this announcement.
LEPU BIO (02157) announced that the Board was notified by Dr. Pu Zhongjie (Dr. Pu, Chairman and Executive Director, and a controlling shareholder of the Company) that on October 27, 2026, he purchased a total of 1.05 million H shares of the Company (H Shares) in the open market through the Shanghai-Hong Kong Stock Connect using his own funds at an average price of approximately RMB3.04 per H Share (approximately HK$3.55), representing approximately 0.06% of the total number of issued shares of the Company as at the date of this announcement.
Related Articles
Citi: TENCENT (00700) 2026 Global Digital Ecosystem Summit May Be a Catalyst; Reiterates "Buy" Rating with Target Price of HK$755
HK Stock Market Move | TENNOR THERAP-B (06872) Surges 16% in Afternoon Session; First Patient Enrolled in Phase IIb Trial of TNP-2092 for Prosthetic Joint Infection
HK Stock Market Move | H&H INTL HLDG (01112) rose nearly 6% in the afternoon; revenue for the first three quarters grew 24.5%; the company raised its full-year revenue expectation.
Citi: TENCENT (00700) 2026 Global Digital Ecosystem Summit May Be a Catalyst; Reiterates "Buy" Rating with Target Price of HK$755
HK Stock Market Move | TENNOR THERAP-B (06872) Surges 16% in Afternoon Session; First Patient Enrolled in Phase IIb Trial of TNP-2092 for Prosthetic Joint Infection
HK Stock Market Move | H&H INTL HLDG (01112) rose nearly 6% in the afternoon; revenue for the first three quarters grew 24.5%; the company raised its full-year revenue expectation.
